Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-01-05 @ 5:46 PM
Study NCT ID:
NCT03350035
Status:
COMPLETED
Last Update Posted:
2023-03-09
First Post:
2017-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
Sponsor:
Marinus Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1042-SE-2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None